SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-201046
Filing Date
2020-07-28
Accepted
2020-07-28 16:45:16
Documents
3
Effectiveness Date
2020-07-28

Document Format Files

Seq Description Document Type Size
1 S-8 d943725ds8.htm S-8 58185
2 EX-5.1 d943725dex51.htm EX-5.1 8043
3 EX-23.2 d943725dex232.htm EX-23.2 1774
  Complete submission text file 0001193125-20-201046.txt   69098
Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Filer) CIK: 0001693011 (see all company filings)

IRS No.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-240146 | Film No.: 201054441
SIC: 2834 Pharmaceutical Preparations